ESR1 and breast cancer: Studies using MCF-7 breast cancer cells show that with lower concentrations (10−7 to 10−5 mol/l) of RES, there is a reduction of cellular proliferation in a dose and time-dependent manner, via an ER-dependent mechanism [12, 13].